Metabolic effects associated with atypical antipsychotic medications.
Despite the plethora of evidence that demonstrates the efficacy of novel antipsychotic medications, there are mounting concerns about their side effects. Major concerns are data that link some agents with metabolic effects, such as obesity, type 2 diabetes, and CVD. For these reasons, patients receiving novel antipsychotic medications must be closely monitored for metabolic side effects and treated to reduce risk factors associated with CVD.
Antai-Otong
Deborah
D
Employee Support Program, VA North Texas Health Care System, Dallas, TX, USA.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D016903:Drug Monitoring; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000517:prevention & control
D014150:Antipsychotic Agents